ACC 2006

Bivalirudin in ACS: The Acuity Study Findings

Michael Lincoff
Michael Lincoff, Cleveland Clilnic, Cleveland Ohio
American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta
The full picture of how bivalirudin is emerging as a treatment without also using glycoprotein IIb/IIIa inhibition in cases of acute coronary syndrome was painted at the Atlanta meeting by Michael Lincoff from the Cleveland Clinic.

Similar Interviews

  • Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY study
  • HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: ACUITY Trial, ACC.07 Scientific Session and i2 Innovations Summit. Presentation Number: 2414-5 Patients with

  • Single Agent Bivalirudin Better for Acute Coronary Syndromes
  • Gregg Stone, Columbia University Medical Center, New York American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta A superiority for

  • Audio Journal of Cardiovascular Medicine: June 2006 - In the company of Michael Petch">Audio Journal of Cardiovascular Medicine: June 2006 - In the company of Michael Petch
  • Annual Meeting of the American College of Cardiology March 11-14, 2006, Atlanta: Single Agent Bivalirudin Better for Acute Coronary Syndromes;

    Post a comment